After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.
Read MoreAfter months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.
Read MoreA scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.
Read MoreLabscoop Welcomes Industry Leading Immunology Antibodies and Ancillary Reagents Manufacturer Tonbo Biosciences. One of the fastest growing life science companies offering high performance, value-oriented products of the highest quality.
Read MoreThe 150,000th article recommendation, published today in F1000Prime (http://f1000.com/prime), identifies an important research article that helps our understanding of how consumption of fish oils could help protect against certain allergies.
Read MoreGreiner Bio One announces new social networking sites for direct customer interaction. The first 50 customers to email mackenziefarone@gbo.com to tell us they "liked" our facebook page, gets $50 off their next purchase!
Read MoreInternational Stem Cell Corporation announced that its oocyte collection and activation protocol has received the approval of an Institutional Review Board, a Federal requirement for all studies enrolling human subjects, and ensures appropriate subj
Read MoreInternational Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company's development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are
Read MoreInternational Stem Cell Corporation, an international pioneer and leader in stem cell research, announced that its wholly owned subsidiary, Lifeline Skin Care Inc., has achieved positive results in human safety tests of its cosmetic products and is m
Read More